COVID-19 vaccines in elderly subjects: Considerations on efficacy and safety
<p>The SARS-CoV-2 pandemic dramatically involved elderly subjects, causing a very high number of deaths in this specific population, with a risk of mortality reaching 50% in subjects older than 80 years [1-3]. As a consequence, as the world prepares for a mass campaign to vaccinate as many peo...
Bewaard in:
Hoofdauteur: | Marco Bongiovanni (Auteur) |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Archives of Clinical Gastroenterology - Peertechz Publications,
2021-05-19.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Gelijkaardige items
-
Some COVID-19 relevant considerations in the elderly
door: Ana Esther Despaigne Biset, et al.
Gepubliceerd in: (2023) -
Considerations for vaccinating children against COVID-19
door: Fiona Russell, et al.
Gepubliceerd in: (2023) -
COVID-19 Vaccine Videos: Health Literacy Considerations
door: Iris Feinberg, et al.
Gepubliceerd in: (2023) -
COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake
door: Kaushal Parimi, et al.
Gepubliceerd in: (2022) -
Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
door: Danielle Gilbert, et al.
Gepubliceerd in: (2023)